CRUPI, EMANUELE
 Distribuzione geografica
Continente #
EU - Europa 105
NA - Nord America 98
AS - Asia 74
Continente sconosciuto - Info sul continente non disponibili 19
SA - Sud America 9
AF - Africa 1
Totale 306
Nazione #
US - Stati Uniti d'America 92
RU - Federazione Russa 71
CN - Cina 27
SG - Singapore 21
IT - Italia 14
BR - Brasile 7
VN - Vietnam 7
HK - Hong Kong 5
BD - Bangladesh 4
CA - Canada 4
FR - Francia 4
JP - Giappone 4
PL - Polonia 4
SE - Svezia 4
ES - Italia 3
IN - India 2
AL - Albania 1
AR - Argentina 1
BE - Belgio 1
CO - Colombia 1
DE - Germania 1
GB - Regno Unito 1
IQ - Iraq 1
MX - Messico 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 287
Città #
San Jose 19
Council Bluffs 12
Singapore 12
Beijing 7
Moscow 7
Hong Kong 5
Ashburn 4
Dallas 4
Ho Chi Minh City 3
Los Angeles 3
New York 3
Warsaw 3
Bologna 2
Brooklyn 2
Catania 2
Cesano Boscone 2
Milan 2
Orem 2
Shanghai 2
Stockholm 2
Tokyo 2
Allentown 1
Aurora 1
Baltimore 1
Boardman 1
Brampton 1
Brussels 1
Cataguases 1
Charlotte 1
Cleveland 1
Corona 1
Da Nang 1
Dakar 1
Denver 1
Erbil 1
Faisalabad 1
Florence 1
Grand Junction 1
Grand Rapids 1
Guelph 1
Haining 1
Haiphong 1
Hefei 1
Lansdowne 1
Lauterbourg 1
Lisbon 1
Loganville 1
London 1
Louveira 1
Medellín 1
Mexico City 1
Milwaukee 1
Naples 1
Nashville 1
Navsari 1
North Kansas City 1
Oldenburg 1
Painesville 1
Palmdale 1
Petrolina 1
Phú Thọ 1
Phủ Lý 1
Pomona 1
Port of Spain 1
Pune 1
Queen Creek 1
Richmond 1
Rio Grande da Serra 1
Riyadh 1
Rome 1
Roubaix 1
Saint-Lazare 1
Salsipuedes 1
San José de la Rinconada 1
Santa Clara 1
Seattle 1
Sesto San Giovanni 1
São Paulo 1
Tashkent 1
Taubaté 1
Tirana 1
Toronto 1
Wendell 1
Westminster 1
Totale 163
Nome #
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 102
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI 70
Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer 42
First results of NURE-Combo: A phase 2 study of neoadjuvant nivolumab (NIVO) and nab-paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with muscle-invasive bladder cancer (MIBC) 26
Comprehensive genomic profiling (CGP) of clinical T2-4N0M0 muscle-invasive bladder cancer (MIBC) treated with neoadjuvant pembrolizumab or cisplatinbased chemotherapy before radical cystectomy (RC) 18
Utility of fluoro-deoxy-glucose positron emission tomography (FDG-PET) to predict a pelvic lymph node involvement (LNI) in patients (pts) with muscle-invasive bladder cancer (MIBC) enrolled in neoadjuvant therapy trials 14
The role of androgen response pathway in association with tumor biology and response to neoadjuvant immune-checkpoint inhibitors (ICI) in muscle-invasive urothelial bladder carcinoma (MIBC) 10
Data from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial 7
Data from Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer 6
Distinct Gene Expression Patterns Identify Patients who Relapse After Neoadjuvant Pembrolizumab and Radical Cystectomy in the PURE-01 Study 6
Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer 5
Totale 306
Categoria #
all - tutte 1.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.317


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20234 0 0 0 1 0 1 1 1 0 0 0 0
2023/20245 0 0 2 1 0 1 0 0 0 0 0 1
2024/202515 1 0 1 0 1 3 1 5 0 1 0 2
2025/2026227 6 6 0 10 26 13 11 19 68 30 22 16
2026/202755 26 29 0 0 0 0 0 0 0 0 0 0
Totale 306